. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: Am Heart J. 2017 Jun 17;191:30–36. doi: 10.1016/j.ahj.2017.06.005

Table 2.

Clinical Outcomes

	Men (n=3502)	Women (n=1416)	P-Value
^*Intervention Performed, (%)	2792 (95.6)	1032 (94.4)	0.10
Length-of-stay (days)	3 (2, 4)	3 (2,5)	<0.001
Door-to-Balloon (mins), median(25^th, 75^th percentile)
PCI Facility	55 (40, 75)	61 (44, 86)	<0.001
Zone 1	94 (80, 117)	99 (84, 124)	<0.001
Zone 2	121 (100, 147)	124 (101, 158)	0.21
PCI Door-to-Balloon ≤ 90 minutes, (%)	789 (86.2)	323 (79.0)	0.001
Zone 1 Door-to-Balloon ≤ 120 minutes, (%)	1231 (78.3)	424 (72.2)	0.003
Zone 2 Received fibrinolytic or Door-to-Balloon ≤ 120 minutes, (%)	804 (84.2)	319 (80.6)	0.11
Discharge Medications^†
Aspirin, (%)	2660 (98.3)	948 (97.1)	0.032
Beta Blocker, (%)	2569 (95.0)	920 (94.6)	0.55
Statin, (%)	2541 (93.9)	889 (91.2)	0.004
Thienopyridine, (%)	2636 (97.4)	935 (95.7)	0.009

Percent based on patients with a known culprit artery

^†

Percent based on patients who received intervention